A61K 35/76
Viruses
Official title: Viruses; Subviral particles; Bacteriophages
A61K35/76 (Viruses) appears on 1,779 US grants and 3,579 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,779
- Published applications
- 3,579
- Assignees
- 1,269
- Inventors
- 5,178
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 9 | 0 |
| 2001 | 13 | 8 |
| 2002 | 11 | 38 |
| 2003 | 16 | 42 |
| 2004 | 19 | 54 |
| 2005 | 6 | 62 |
| 2006 | 19 | 45 |
| 2007 | 30 | 52 |
| 2008 | 22 | 68 |
| 2009 | 23 | 69 |
| 2010 | 30 | 74 |
| 2011 | 35 | 86 |
| 2012 | 45 | 79 |
| 2013 | 52 | 110 |
| 2014 | 52 | 100 |
| 2015 | 67 | 104 |
| 2016 | 64 | 134 |
| 2017 | 72 | 139 |
| 2018 | 90 | 164 |
| 2019 | 96 | 282 |
| 2020 | 129 | 310 |
| 2021 | 115 | 290 |
| 2022 | 153 | 313 |
| 2023 | 146 | 244 |
| 2024 | 136 | 289 |
| 2025 | 182 | 234 |
| 2026 | 122 | 189 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Bacteriophage compositions for treating Staphylococcus infection6 Oct 2026US 12,751,983 B2Armata Pharmaceuticals, Inc.
- Dengue vaccine unit dose and administration thereof29 Sep 2026US 12,746,283 B2Takeda Vaccines, Inc.
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Chimeric antigen receptors to HER2 and methods of use thereof22 Sep 2026US 12,742,020 B2BioAtla, Inc.
- Methods and materials for treating cancer8 Oct 2026US 2026/0306566 A1Mayo Foundation for Medical Education and Research
- Tumor neoantigen vaccine system specifically marking heterologous protein, and use thereof8 Oct 2026US 2026/0306620 A1China Pharmaceutical University
- Recombinant herpes simplex virus with il-12 expression8 Oct 2026US 2026/0308219 A1
- Expression cassette coding for vascular endothelial growth factor8 Oct 2026US 2026/0308618 A1Cornell University
- Compositions comprising smyd1 and methods of use thereof8 Oct 2026US 2026/0308621 A1
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject132US 6,428,968 B1The Trustees of the University of Pennsylvania · 2002
- AAV's and uses thereof123US 8,734,809 B2University of Massachusetts · 2014